Product Details
Janumet
Sitagliptin + Metformin50 mg + 850 mg
Tablet
DIN/PIN/NPN
02333864
Manufacturer
Merck Canada Inc.
Formulary Listing Date
2012-02-29
Unit Price
1.7785
Amount MOH Pays
0.8893
Coverage Status
General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Sitagliptin + Metformin 50 mg + 850 mg Tablet: Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.
ATC Code
A10BD07
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02333864 | Janumet | 1.7785 | 0.8893 |
| 02509423 | Apo-Sitagliptin Malate/Metformin HCl | 0.8893 | 0.8893 |
| 02503964 | Sandoz Sitagliptin-Metformin | 0.8893 | 0.8893 |